Cargando…
Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival
SIMPLE SUMMARY: The improved survival rates of lung cancer patients have led to an increased number of patients experiencing multiple primary malignancies during the course of their life. Therefore, a tool that can evaluate the risk of multiple primary cancers and detect them as early as possible co...
Autores principales: | Kudura, Ken, Ritz, Nando, Templeton, Arnoud J., Kissling, Marc, Kutzker, Tim, Foerster, Robert, Hoffmann, Martin H. K., Antwi, Kwadwo, Kreissl, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001246/ https://www.ncbi.nlm.nih.gov/pubmed/36900312 http://dx.doi.org/10.3390/cancers15051521 |
Ejemplares similares
-
Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors
por: Kudura, Ken, et al.
Publicado: (2022) -
Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition
por: Kudura, Ken, et al.
Publicado: (2023) -
An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data
por: Kudura, Ken, et al.
Publicado: (2023) -
Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021) -
Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)